Filing Details
- Accession Number:
- 0001209191-20-013034
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-26 16:36:28
- Reporting Period:
- 2020-02-24
- Accepted Time:
- 2020-02-26 16:36:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406338 | Amit Sachdev | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Chief Patient Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-24 | 3,156 | $239.23 | 36,291 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-02-25 | 953 | $230.00 | 35,338 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 270 | $230.98 | 35,068 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 450 | $232.62 | 34,618 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 90 | $233.18 | 34,528 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 533 | $234.56 | 33,995 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 360 | $235.75 | 33,635 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 180 | $236.63 | 33,455 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 540 | $238.33 | 32,915 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 16,190 | Indirect | Held in Trust |
| Common Stock | 882 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $230.00 (range $229.52 to $230.31).
- Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $230.98 (range $230.57 to $231.26).
- Open market sales reported on this line occurred at a weighted average price of $232.62 (range $232.06 to $233.05).
- Open market sales reported on this line occurred at a weighted average price of $234.56 (range $234.27 to $234.66).
- Open market sales reported on this line occurred at a weighted average price of $235.75 (range $235.63 to $235.82).
- Open market sales reported on this line occurred at a weighted average price of $238.33 (range $238.16 to $238.54).
Billionaire Hedge Funds
